Nav: Home

Nuclear transfer of mitochondrial DNA in colon and rectal cancer

April 12, 2017

BIRMINGHAM, Ala. - Patients with colon and rectal cancer have somatic insertions of mitochondrial DNA into the nuclear genomes of the cancer cells, University of Alabama at Birmingham researchers report in the journal Genome Medicine.

This study provides the novel role for mitochondria inducing genomic instability in the nucleus of cancer cells, the UAB researchers say.

Overall, a study of the genome sequences of 57 colorectal cancers showed, on average, 4.42-fold more somatic nuclear mitochondrial DNA as compared to matched healthy blood controls. This suggests that migration of mitochondrial DNA into the nuclear genome plays an important role in development of cancer, say corresponding authors Hemant K. Tiwari, Ph.D., and Keshav K. Singh, Ph.D. Tiwari is professor of biostatistics in the UAB School of Public Health, and Singh is professor of genetics in the UAB School of Medicine.

Numerous mitochondrial organelles reside in nearly all higher eukaryotic cells, and they function as the powerhouses of the cells to create ATP, the cell's major energy source. Human mitochondria have just 37 genes. The mitochondria are located in the cytosol of the cells, outside of the cell nucleus; the cell's DNA genome is located inside the nuclear membrane.

Over eons, pieces of mitochondrial DNA have naturally inserted into eukaryotic genomes; at birth, for example, humans have between 755 and 1,155 germline mitochondrial DNA inserts that have been passed on through generations. These germline, inherited mitochondrial DNA insertions are seen over a wide range of organisms, including humans, plants, yeast, malaria parasites and nematodes.

Besides DNA, entire mitochondria, mitochondrial proteins and mitochondrial RNA can also be found in the nucleus; but their roles in human health and disease remain relatively unexplored. The increased mitochondrial DNA in the genomes of the cancer cells observed by the UAB team suggests somatic insertion of mitochondrial DNA occurred as the cancer developed.

The median nuclear mitochondrial DNA fold-change in colorectal tumors of women was higher than the median for men. There appeared to be a correlation of increased fold-change with poorer patient survival, but the researchers say further analysis of a larger sample size is needed to make a definite conclusion.

The somatic mitochondrial DNA inserts appeared to correlate with gene-rich segments of the genome, and the researchers mapped hotspots on the mitochondrial genome for migration into the nuclear genome.

Since the gene product of YME1 is a potent suppressor of mitochondrial DNA migration into the genome of the yeast Saccharomyces cerevisiae, Tiwari and Singh investigated the human homologue of the YME1 gene, called YME1L1. Both gene products have conserved roles in mitochondrial assembly (mitochondria are made up of 2,000 proteins encoded by the nuclear genome and 13 encoded by the mitochondrial genome), mitochondrial integrity and DNA metabolism. However, a role for the human YME1L1 in suppressing migration of mitochondrial DNA into the nucleus was unknown.

As indirect evidence, the UAB researchers found that 16 percent of the 57 colorectal cancer sequences examined had mutations in the human gene YME1L1. An expanded analysis of colorectal cancer sequences in The Cancer Genome Atlas database showed a high incidence of YME1L1 mutations. The researchers also found high mutation rates of YME1L1 in other cancers.

The UAB team next showed that knocking out YME1L1 in a human cell line strikingly increased the amount of mitochondrial DNA in the nuclear fraction of YME1L1 knockout cells. These results identified YME1L1 as the first reported suppressor gene for nuclear migration of mitochondrial DNA in humans, and they suggested that inactivation of YME1L1 leads to increased migration of mitochondrial DNA into the nucleus.

This was tested in yeast. A marker that can only be transcribed in the nucleus was inserted into yeast mitochondrial DNA. When the yeast YME1 was mutated, the marker was 20-fold elevated compared to yeast with non-mutated YME1. When human YME1L1 was introduced into yeast with the mutated YME1, the human gene product partially rescued the YME1 mutation, preventing migration of mitochondrial DNA into the nucleus. Thus, human YME1L1 appears to suppress migration of mitochondrial DNA into the nucleus.

Tiwari and Singh have dubbed a new term -- numtogenesis (pronounced "noo-mitto-genesis") -- for this phenomenon of mitochondrial occurrence in the nucleus.

In a companion paper in Analytical Biochemistry, the Singh laboratory and the Bernd Friebe laboratory at the Department of Plant Pathology, Kansas State University, describe a molecular tool to rapidly detect and analyze insertion of mitochondrial DNA into the genomes of cells.

Up to now, analysis of mitochondrial DNA inserted into the nuclear genome depended on deep genome sequencing combined with comprehensive computational analysis of the entire genome, a time-consuming, cumbersome and cost-prohibitive approach. The researchers, led by corresponding author Singh and first author Dal-Hoe Koo, research assistant professor at Kansas State, developed a single-molecule mitochondrial Fiber-FISH technique, using fluorescence in situ hybridization. This permits high-resolution mapping of genes and chromosomal regions on single fibers of DNA, and it targets the physical location of mitochondrial DNA probes down to a resolution of 1,000 base pairs.

"This novel technique," they said, "should help distinguish and monitor cancer stages and progression, aid in elucidation of basic mechanisms underlying tumorigenesis, and facilitate analyses of processes related to early detection of cancer, screening and/or cancer risk assessment."

Besides Tiwari and Singh, co-authors of the Genome Medicine paper, "Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma," are Vinodh Srinivasainagendra, Michael W. Sandel, Bhupendra Singh, Aishwarya Sundaresan, Ved P. Mooga and Prachi Bajpai, UAB departments of Biostatistics and Genetics.

Besides Singh, Friebe and Koo, co-authors of the Analytical Biochemistry paper, "Single-molecule mtDNA Fiber FISH for analyzing numtogenesis," are Jiming Jiang, University of Wisconsin-Madison; Bikarm S. Gill, Kansas State University; Paul D. Chastain, William Carey University, Hattiesburg, Mississippi; and Bhupendra Singh, Upender Manne and Hemant K. Tiwari, UAB.

At UAB, Tiwari holds the William "Student" Sealy Gosset Endowed Professorship in Biostatistics, UAB School of Public Health, and Singh holds Joy and Bill Harbert Endowed Chair in Cancer Genetics.
-end-


University of Alabama at Birmingham

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.